Kantarjian H - Search Results

1

Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study.

Shah NP, Talpaz M, Deininger MW, Mauro MJ, Flinn IW, Bixby D, Lustgarten S, Gozgit JM, Clackson T, Turner CD, Haluska FG, Kantarjian H, Cortes JE. Shah NP, et al. Among authors: kantarjian h. Br J Haematol. 2013 Aug;162(4):548-52. doi: 10.1111/bjh.12382. Epub 2013 May 21. Br J Haematol. 2013. PMID: 23691988 Free PMC article. Clinical Trial. No abstract available.

2

Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation.

Lee M, Khouri I, Champlin R, Kantarjian H, Talpaz M, Trujillo J, Freireich E, Deisseroth A, Stass S. Lee M, et al. Among authors: kantarjian h. Br J Haematol. 1992 Dec;82(4):708-14. doi: 10.1111/j.1365-2141.1992.tb06948.x. Br J Haematol. 1992. PMID: 1482658

3

Activation of class I HLA expression by TNF-alpha and gamma-interferon is mediated through protein kinase C-dependent pathway in CML cell lines.

Seong D, Sims S, Johnson E, Lyding J, Lopez A, Garovoy M, Talpaz M, Kantarjian H, Lopez-Berestein G, Reading C, et al. Seong D, et al. Among authors: kantarjian h. Br J Haematol. 1991 Jul;78(3):359-67. doi: 10.1111/j.1365-2141.1991.tb04449.x. Br J Haematol. 1991. PMID: 1908310

4

Interferon alpha in the therapy of CML.

Talpaz M, Kantarjian H, Kurzrock R, Gutterman JU. Talpaz M, et al. Among authors: kantarjian h. Br J Haematol. 1991 Oct;79 Suppl 1:38-41. doi: 10.1111/j.1365-2141.1991.tb08117.x. Br J Haematol. 1991. PMID: 1931707

5

Biologic agents for the management of hematological disorders: chronic myeloid leukemia.

McCredie KB, Talpaz M, Kantarjian H, Rosenblum M, Keating M, Gutterman J. McCredie KB, et al. Among authors: kantarjian h. Haematol Blood Transfus. 1987;31:120-2. doi: 10.1007/978-3-642-72624-8_25. Haematol Blood Transfus. 1987. PMID: 2450815 No abstract available.

6

Therapy of chronic myelogenous leukaemia with interferons.

Talpaz M, Kurzrock R, Kantarjian H, Gutterman J. Talpaz M, et al. Among authors: kantarjian h. Cancer Surv. 1989;8(4):793-8. Cancer Surv. 1989. PMID: 2701727 Review.

7

Chronic myelogenous leukaemia: haematological remissions with alpha interferon.

Talpaz M, McCredie K, Kantarjian H, Trujillo J, Keating M, Gutterman J. Talpaz M, et al. Among authors: kantarjian h. Br J Haematol. 1986 Sep;64(1):87-95. doi: 10.1111/j.1365-2141.1986.tb07576.x. Br J Haematol. 1986. PMID: 3463363

8

Low-dose interferon-alpha in chronic myeloid leukemia.

Talpaz M, Kantarjian H. Talpaz M, et al. Among authors: kantarjian h. Ann Intern Med. 1995 May 1;122(9):728-9. doi: 10.7326/0003-4819-122-9-199505010-00013. Ann Intern Med. 1995. PMID: 7702237 No abstract available.

9

Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.

Cortes JE, Kantarjian H, O'Brien S, Keating M, Pierce S, Freireich EJ, Estey E. Cortes JE, et al. Among authors: kantarjian h. Leukemia. 1995 Jan;9(1):115-7. Leukemia. 1995. PMID: 7845005

10

Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.

Cortes J, Kantarjian H, O'Brien S, Robertson LE, Pierce S, Talpaz M. Cortes J, et al. Among authors: kantarjian h. Am J Med. 1996 Apr;100(4):452-5. doi: 10.1016/s0002-9343(97)89522-8. Am J Med. 1996. PMID: 8610733 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,541 results

Search Page

Filters